Africa’s pharmaceutical market, valued at approximately $28.56 billion in 2020, is projected to reach $70 billion by 2030. This growth is driven by population expansion, urbanisation, and an increasing prevalence.
Once seen as the world’s patient, Africa is now transforming into its physician. With resilience and collaboration, the continent is reshaping global health paradigms. From pioneering public health initiatives to.
By: Fumnaya Ijeh The Economic Community of West African States, ECOWAS, on Wednesday, signed an agreement with the African Development Bank, AfDB to boost the pharmaceutical industry in West Africa.
By Walcott Aganu The COVID-19 pandemic has hampered efforts to meet the Sustainable Development Goals of the 2030 Agenda. The global community is in an unprecedented scenario, with simultaneous threats.
Poised to serve as a catalyst for trade development for IOC members countries, the International Islamic Finance Corporation, ITFC, has continued to assist organizations in member countries to gain better.
African Export-Import Bank (Afreximbank) has said that African countries should develop manufacturing capabilities in pharmaceuticals and reduce the level of import of equipment and medicines in order to conserve foreign.
African multinationals are expanding their footprint across global markets; companies are leveraging their regional strengths and capitalising on new growth opportunities worldwide. Recent reports highlight a trajectory of African multinationals.
In this exclusive interview with Mr. Poonoosamy, the head of the Economic Development Board of Mauritius, he reflects on the pivotal moments of his tenure. He highlights the EDB’s role.
The awful truth about emerging African economic greatness is beginning to dawn on the world. Don’t butt in to think it’s going to be a fleeting excitement. Never. It will.
By Wole Oyebade and Femi Adekoya It was a sombre afternoon, early 2020 when the bad news wafted across the globe. The world battling its worst pandemic in 100 years was.
